Alembic
Ticker > Company >

Alembic share price

Alembic Ltd.

NSE: ALEMBICLTD BSE: 506235 SECTOR: Pharmaceuticals & Drugs  1.1 L   319   64

106.65
-0.20 (-0.19%)
BSE: 18 Sep 04:01 PM

Price Summary

Today's High

₹ 107.5

Today's Low

₹ 106.25

52 Week High

₹ 153.45

52 Week Low

₹ 85.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2738.58 Cr.

Enterprise Value

₹ 2748.84 Cr.

No. of Shares

25.68 Cr.

P/E

19.25

P/B

3.15

Face Value

₹ 2

Div. Yield

2.25 %

Book Value (TTM)

₹  33.89

CASH

₹ 4.19 Cr.

DEBT

₹ 14.45 Cr.

Promoter Holding

70.88 %

EPS (TTM)

₹  5.54

Sales Growth

40.79%

ROE

17.08 %

ROCE

18.25%

Profit Growth

52.82 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year40.79%
3 Year41.31%
5 Year23.81%

Profit Growth

1 Year52.82%
3 Year18.31%
5 Year8.7%

ROE%

1 Year17.08%
3 Year12.34%
5 Year9.68%

ROCE %

1 Year18.25%
3 Year13.35%
5 Year10.64%

Debt/Equity

0.0169

Price to Cash Flow

33.8

Interest Cover Ratio

84.0632

CFO/PAT (5 Yr. Avg.)

0.285784472345378

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 70.88 0.00
Mar 2025 70.88 0.00
Dec 2024 70.88 0.00
Sep 2024 70.88 0.00
Jun 2024 70.88 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 18.3106221807773% for the Past 3 years.
  • The company has shown a good revenue growth of 41.3054628889372% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 84.0632.
  • The Company has been maintaining an effective average operating margins of 28.1068107250428% in the last 5 years.
  • Company’s PEG ratio is 0.364540867115547.
  • The company has an efficient Cash Conversion Cycle of 49.0158 days.
  • The company has a high promoter holding of 70.88%.

 Limitations

  • Tax rate is low at 6.607.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 49.08 51.1 55.97 58.22 47.89
Total Expenditure 29.63 32.72 30.25 32.21 29.31
Operating Profit 19.45 18.38 25.72 26.01 18.58
Other Income 1.89 65.59 4.24 2.78 3.45
Interest 0.34 0.51 0.52 0.45 0.42
Depreciation 2.41 2.59 2.59 2.66 2.7
Exceptional Items 0 0 0 0 0
Profit Before Tax 18.59 80.87 26.85 25.68 18.91
Tax 1.75 4.27 1.16 2.85 1.79
Profit After Tax 16.84 76.6 25.69 22.83 17.12
Adjusted EPS (Rs) 0.66 2.98 1 0.89 0.67

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 72.3 75.97 123.16 152.25 214.36
Total Expenditure 62.21 63.06 85.15 96 124.8
Operating Profit 10.09 12.92 38.01 56.25 89.55
Other Income 10.61 89.09 64.11 54.62 74.51
Interest 0.27 0.23 0.16 0.69 1.83
Depreciation 3.91 4.5 6.36 7.46 10.24
Exceptional Items 0 0 -10.61 0 0
Profit Before Tax 16.52 97.28 85 102.72 151.99
Tax 3.15 11.56 5.73 9.83 10.04
Net Profit 13.36 85.71 79.27 92.89 141.95
Adjusted EPS (Rs.) 0.52 3.34 3.09 3.62 5.53

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 51.36 51.36 51.36 51.36 51.36
Total Reserves 775.46 962.49 777.63 757.4 801.83
Borrowings 0 0 0 7.39 10.67
Other N/C liabilities 51.24 63.45 38.12 40.54 37.69
Current liabilities 58.39 66.89 86.95 94.71 124.35
Total Liabilities 936.45 1144.19 954.06 951.4 1025.9
Assets
Net Block 133.69 133.5 131.83 130.54 135.33
Capital WIP 37.27 0.19 0.13 1.1 0
Intangible WIP 0 0 0 0 0
Investments 565.5 702.38 461.07 399.78 364.11
Loans & Advances 0.85 4.98 0 35 35
Other N/C Assets 99.53 162.9 187.96 245.94 279.09
Current Assets 99.62 140.23 173.07 139.05 212.38
Total Assets 936.45 1144.19 954.06 951.4 1025.9
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 16.52 97.28 85 102.72 151.99
Adjustment 1.54 -79.16 -53.46 -42.82 -53.74
Changes in Assets & Liabilities -17.22 -31.35 9.59 -36.22 -2.71
Tax Paid -1.95 -8.64 -6.43 1.65 -14.51
Operating Cash Flow -1.12 -21.87 34.7 25.33 81.03
Investing Cash Flow -35.15 22.66 11.29 22.6 -21.79
Financing Cash Flow -15.27 -5.66 -46.08 -47.77 -57.7
Net Cash Flow -51.53 -4.86 -0.09 0.16 1.54

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 70.88 70.88 70.88 70.88 70.88
chirayu ramanbhai amin 3.24 3.24 3.24 3.24 3.24
inaaya shaunak amin 0.02 0.02 0.02 0.02 0.02
malika chirayu amin 2.99 2.99 2.99 2.99 2.99
naintara shaunak amin 0.02 0.02 0.02 0.02 0.02
nirayu limited 63.06 63.06 63.06 63.06 63.06
pranav chirayu amin 0.75 0.75 0.75 0.75 0.75
ranvir pranav amin 0.02 0.02 0.02 0.02 0.02
samira pranav amin 0.02 0.02 0.02 0.02 0.02
shaunak chirayu amin 0.75 0.75 0.75 0.75 0.75
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 29.12 29.12 29.12 29.12 29.12
investor education and pr... 1.20 1.25 - 1.27 1.27
llp 0.04 0.06 0.05 0.06 0.05
investor education and pr... - - 1.29 - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research BOB Capital Market

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Alembic - Quaterly Results 12 Aug, 3:52 PM Alembic - Quaterly Results 12 Aug, 3:52 PM Alembic - Quaterly Results 12 Aug, 3:52 PM Alembic informs about newspaper publication 5 Jul, 2:31 PM Alembic submits BRSR 4 Jul, 4:34 PM Alembic informs about press release 16 May, 4:57 PM Alembic - Quaterly Results 13 May, 5:30 PM Alembic - Quaterly Results 13 May, 5:30 PM Alembic - Quaterly Results 13 May, 5:30 PM Alembic informs about completion of tenure of independent director 25 Feb, 10:28 AM Alembic - Quaterly Results 7 Feb, 5:50 PM Alembic - Quaterly Results 7 Feb, 5:50 PM Alembic - Quaterly Results 7 Feb, 5:50 PM Alembic reports 50% rise in Q2 consolidated net profit 9 Nov, 3:07 PM Alembic - Quaterly Results 8 Nov, 5:03 PM Alembic - Quaterly Results 8 Nov, 5:03 PM Alembic informs about board meeting 29 Oct, 11:55 AM Alembic - Quaterly Results 12 Aug, 3:55 PM Alembic - Quaterly Results 12 Aug, 3:55 PM Alembic - Quaterly Results 12 Aug, 3:55 PM Alembic informs about loss of share certificate 26 Jul, 12:30 PM Alembic informs about annual report 11 Jul, 5:08 PM Alembic informs about record date 11 Jul, 4:43 PM Alembic informs about loss of share certificates 18 Jun, 5:28 PM Alembic informs about loss of share certificate 6 Jun, 1:07 PM Alembic informs about loss of share certificate 25 May, 10:30 AM Alembic informs about postal ballot notice 24 May, 12:16 PM Alembic reports over 4-fold jump in Q4 consolidated net profit 14 May, 2:18 PM Alembic - Quaterly Results 13 May, 6:32 PM Alembic - Quaterly Results 13 May, 6:32 PM Alembic informs about loss of share certificates 6 May, 2:36 PM Alembic informs about loss of share certificate 16 Apr, 12:14 PM Alembic informs about details of loss of certificate 6 Apr, 3:32 PM Alembic informs about loss of share certificate 1 Apr, 5:02 PM Alembic informs about loss of share certificate 27 Feb, 2:28 PM Alembic informs about loss of share certificate 24 Feb, 11:07 AM Alembic informs about loss of share certificate 22 Feb, 2:04 PM Alembic submits unaudited financial results 14 Feb, 5:19 PM Alembic - Quaterly Results 14 Feb, 4:54 PM Alembic - Quaterly Results 14 Feb, 4:54 PM Alembic informs about loss of share certificate 16 Jan, 4:48 PM Alembic informs about loss of share certificate 9 Jan, 3:53 PM Alembic informs about details of loss of certificate 4 Dec, 4:32 PM Alembic informs about loss of share certificates 17 Nov, 5:07 PM Alembic informs about loss of share certificates 16 Oct, 4:26 PM Alembic informs about appointment of independent director 11 Aug, 10:10 AM Alembic informs about voting results and scrutinizers' report 11 Aug, 10:09 AM Alembic informs about board decision 10 Aug, 5:06 PM Alembic - Quaterly Results 10 Aug, 4:07 PM Alembic - Quaterly Results 10 Aug, 4:07 PM

Alembic Stock Price Analysis and Quick Research Report. Is Alembic an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Alembic. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Alembic has a PE ratio of 19.2244507428736 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Alembic has ROA of 14.3576% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Alembic has a Current ratio of 1.7079.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Alembic has a ROE of 17.082%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Alembic has a Debt to Equity ratio of 0.0169 which means that the company has low proportion of debt in its capital.

  • Sales growth: Alembic has reported revenue growth of 40.7934% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Alembic for the current financial year is 41.7774199131453%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Alembic is Rs 2.4 and the yield is 2.2567%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Alembic is Rs 5.5393. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Alembic in Ticker for free. Also, one can get the intrinsic value of Alembic by using Valuation Calculators, which are available with a Finology ONE subscription. 

Alembic FAQs

Q1. What is Alembic share price today?
Ans: The current share price of Alembic is Rs 106.49.

Q2. What is the market capitalisation of Alembic?
Ans: Alembic has a market capitalisation of Rs 2734.469686372 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Alembic?
Ans: The PE ratio of Alembic is 19.2244507428736 and the P/B ratio of Alembic is 3.14194671466084, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Alembic share?
Ans: The 52-week high share price of Alembic is Rs 153.39, and the 52-week low share price of Alembic is Rs 85.46.

Q5. Does Alembic pay dividends?
Ans: Currently, Alembic pays dividends. Dividend yield of Alembic is around 2.2567%.

Q6. What are the face value and book value of Alembic shares?
Ans: The face value of Alembic shares is Rs 2, while the book value per share of Alembic is around Rs 33.893. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Alembic?
Ans: Alembic has a total debt of Rs 14.4473 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Alembic?
Ans: The ROE of Alembic is 17.082% and ROCE of Alembic is 18.2515%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Alembic a good buy for the long term?
Ans: The Alembic long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Alembic undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Alembic appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Alembic’s financials?
Ans: You can review Alembic’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Alembic

Alembic Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Alembic Ltd. is one of the leading pharmaceutical companies in India. With a rich history spanning over a century, the company has established itself as a key player in the healthcare industry. Founded in 1907, Alembic has consistently focused on innovation, research, and development to bring high-quality and affordable medicines to people across the globe.

Alembic Ltd. - Share Price

The share price of Alembic Ltd. reflects the market valuation of the company's stock. As a long-term investor, it is essential to analyze the share price trends over a period of time, taking into account factors such as market conditions, company performance, and industry outlook. Our website provides a detailed stock analysis page, where you can track Alembic Ltd.'s share price along with various technical indicators.

Alembic Ltd. - Balance Sheet

Analyzing a company's balance sheet is crucial for understanding its financial health. Alembic Ltd.'s balance sheet showcases its assets, liabilities, and shareholders' equity. By studying this financial statement, investors can gauge the company's liquidity, solvency, and ability to generate profits. Our website offers pre-built screening tools that enable you to perform a comprehensive analysis of Alembic Ltd.'s balance sheet.

Alembic Ltd. - Annual Report

The annual report of Alembic Ltd. provides valuable insights into the company's performance, strategy, and future prospects. It is a comprehensive document that includes financial statements, management discussion and analysis, and other relevant information. As a long-term investor, reviewing the annual report can help you make informed decisions. You can easily access and download Alembic Ltd.'s annual reports from our website.

Alembic Ltd. - Dividend

Dividends are an important aspect of a company's financial strength and shareholder returns. Alembic Ltd. has a consistent track record of rewarding its shareholders through regular dividend payments. By analyzing the dividend history, investors can assess the company's stability and commitment to sharing profits with its shareholders. Our website provides dividend-related information and tools to help you evaluate Alembic Ltd.'s dividend history.

Alembic Ltd. - Quarterly Result

Tracking a company's quarterly results is crucial for understanding its performance and growth trajectory. Alembic Ltd.'s quarterly results provide insights into its revenue, expenses, and profitability on a quarterly basis. By analyzing these results, investors can monitor the company's operational efficiency and financial stability. Our website offers pre-built screening tools that allow you to easily access and analyze Alembic Ltd.'s quarterly results.

Alembic Ltd. - Stock Price

The stock price of Alembic Ltd. is determined by market forces and reflects the perceived value of the company. Analyzing the stock price trends can provide valuable insights into market sentiment and investor expectations. Our website provides a stock analysis page with detailed information on Alembic Ltd.'s stock price, technical indicators, and performance relative to its peers.

Alembic Ltd. - Price Chart

Price charts are powerful tools that help investors visualize the historical movement of a stock's price. Alembic Ltd.'s price chart captures the fluctuations in its stock price over a specific period. By analyzing the price chart, investors can identify patterns, trends, and support/resistance levels. Our website offers pre-built screening tools that include price charts, allowing you to analyze and interpret Alembic Ltd.'s price movements.

Alembic Ltd. - News

Staying updated with the latest news and developments related to Alembic Ltd. is essential for making informed investment decisions. Our website provides a dedicated news section where you can find the latest news articles, press releases, and market updates related to Alembic Ltd. With access to reliable news sources, investors can stay ahead of market trends and gain a deeper understanding of the company's performance.

Alembic Ltd. - Concall Transcripts

Concall transcripts provide valuable insights into the discussions, decisions, and future plans of a company's management. By analyzing Alembic Ltd.'s concall transcripts, investors can gain a deeper understanding of the company's strategy, outlook, and risk factors. Our website provides downloadable concall transcripts, allowing you to stay informed about Alembic Ltd.'s management discussions.

Alembic Ltd. - Investor Presentations

Investor presentations are an important source of information for understanding a company's business model, growth strategy, and financial performance. Alembic Ltd.'s investor presentations provide a comprehensive overview of the company, including its operations, financials, and future prospects. Our website offers downloadable investor presentations, enabling investors to access and analyze Alembic Ltd.'s key investment highlights.

Alembic Ltd. - Promoters

Promoters play a crucial role in the success and growth of a company. Alembic Ltd. has a strong promoter group that has been instrumental in the company's journey. Our website provides detailed information about Alembic Ltd.'s promoters, their background, and their contributions to the company's success. Understanding the promoters' track record and vision can provide valuable insights for long-term investors.

Alembic Ltd. - Shareholders

Analyzing a company's shareholder base can provide insights into its ownership structure and investor sentiment. Alembic Ltd. has a diverse group of shareholders, including retail and institutional investors. Our website offers information about Alembic Ltd.'s major shareholders and their holdings. Understanding the shareholder composition can help investors gauge market confidence and assess the level of institutional support for the company.

At our website, we provide premium features that offer advanced tools for fair value calculation, including DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis. These tools enable long-term investors to evaluate Alembic Ltd.'s intrinsic value, assess its financial performance, and make informed investment decisions.

In addition, we offer a wide range of downloadable resources, including annual reports, concall transcripts, investor presentations, credit ratings, and research reports. These resources provide comprehensive information and analysis to help investors thoroughly evaluate Alembic Ltd. and make informed investment decisions.

Please note that this content is written in a technical tone and is specifically geared towards long-term stock investors looking for stock analysis. 

Alembic Company's Reserves Trend

Alembic's reserves reflected a positive trend until Mar 2022, reaching a peak of Rs 962.49 Cr, before witnessing a slight downturn in the subsequent years down to Rs 757.40 Cr in Mar 2024. This indicates the company's retained earnings could have been affected by various operational and strategic maneuvers in recent fiscal years.

The Stability of Alembic's Balance Sheet

Over the years from Mar 2020 to Mar 2024, Alembic's balance sheet showcases a steady share capital at Rs 51.36 Cr, with total liabilities and assets balancing out each year. The Mar 2024 figures demonstrate total liabilities and assets at Rs 951.40 Cr, signaling a consistent foundation in the company's financial structure.

Alembic's Debt Introduction

Notably, Alembic introduced borrowings in Mar 2024, at Rs 7.39 Cr. This is a new development in the company's financing strategy, as it maintained a zero-borrowing stance in previous years. This could reflect a shift towards leveraging for growth or investment opportunities.

Assets Management by Alembic

Alembic has managed its assets with slight variations over the observed periods. While net block assets decreased marginally to Rs 130.54 Cr by Mar 2024, investments were significantly reduced from a high of Rs 702.38 Cr in Mar 2022 to Rs 399.78 Cr in Mar 2024. Such changes may be a result of asset reallocation or divestment strategies.

This analysis is based on the Standalone Balance Sheet of the company. In the ever-evolving stock market, this data remains integral for investors tracking performance on NSE/BSE indices, forming a crucial part of stock screening processes.

Read More
X